Login

James P. Scriven, CEO of IDB Invest, explores Latin American finance and investment strategies with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
LiberO: Overcoming Challenges to Unlock Colombia's Copper Potential
00:10:00
How Project 44 and Amber Road Add More Value for Their Clients | Andrew Appel, Chief Executive Officer, Amber Road Inc AMBR:NYQ
00:10:00
Revolutionizing Graphite Production with Low-Cost, High-Quality Strategy
00:00:00
Interests are in clinical cardiac electrophysiology / Jagmeet Singh, M.D., Ph.D.
00:10:00
IRC Ltd: Overcoming Challenges and Advancing Iron Ore Production in Russia
00:10:00
Paul Henrietti Reflects on Sanlam's Challenges and Future Amidst Global Turbulence | Paul Hanratty, CEO, Sanlam.
00:10:00
Own capital is able to define and implement its own long-term strategic goals|Robert R. Dyson, Chairman,The Dyson-Kissner-Moran Corporation
00:10:00
Event-driven analysis of Temenos AG reveals extremely negative sentiments, with most sell-side analysts recommending Sell or Neutral positions.
00:10:00
ATENOR: Shaping Cities, Embracing Values, and Navigating Challenges with Optimism|CEO , Atenor SA
00:10:00
Caledonia Mining's Strategic Expansion: Self-Funded Growth and Future Prospects
00:10:00
We are Advancing Immunology Solutions for a Better Future|Thomas K Equels, Chief Executive Officer,Hemispherx BioPharma
00:10:00
Investing in Preschool Education and Affordable Housing for Singapore's Future | Piyush Gupta , CEO,  DBS Bank .

© 2017 - Neuhu+